Movements in Judaism Zionism Richard JH Gottheil NY 1914 258pgs REL
Contents of Previous Volumes - link.springer.com978-0-306-47193-3/1.pdf · Current Status of the...
Transcript of Contents of Previous Volumes - link.springer.com978-0-306-47193-3/1.pdf · Current Status of the...
Contents of Previous Volumes
Volume 1
1. The Role of Genetics in the Expression of Alcoholism
Overview Donald Goodwin Twin Adoption Studies: How Good Is the Evidence for a Genetic Role
Pharmacogenetic Approaches to the Neuropharmacology of Ethanol
Henri Begleiter, Section Editor
Robin M. Murray, Christine A. Clifford, and Hugh M.D. Gurling
PetersonDennis R.
II. The Behavioral Treatment of Alcoholism
Overview Edward Gottheil How Environments and Persons Combine to Influence Problem Drinking: Current
Alcoholism: The Evolution of a Behavioral Perspective William H. George and G.
Behavioral Treatment Methods for Alcoholism Outcome Studies on Techniques in Alcoholism Treatment
Contributions to Behavioral Treatment from Studies on Programmed Access to
Current Status of the Field: Contrasting Perspectives
Edward Gottheil, Section Editor
Research Issues G.N. Barucht
Alan Marlatt Glenn R. Caddy and Trudy Block
Gloria K. Litman and Anne Topham
Alcohol
Therapist's View Behavioral Interventions S.H. Lovibond C. A Medical Clinician’s Perspective Robert A. Moore D. An Anthropological Perspective on the Behavior Modification Treatment of Alcoholism
Glen R. Caddy and Edward Gottheil A. The Behavioral
Mark B. Sobell and Linda C. Sobell B. The Future of
David Levinson
III. Social Mediators of Alcohol Problems: Movement toward Prevention Strategies Alfonso Paredes, Section Editor
Overview Alfonso Paredes Estimating Alcoholic Prevalence The Role of Alcohol Availability in Alcohol Consumption and Alcohol
Charles J. Furst
Problems Jerome Rabow and Ronald K. Watts
437
438 Contents of Previous Volumes
Price and Income Elasticities and the Demand for Alcoholic Beverages
Youth, Alcohol, and Traffic Accidents: Current Status
Stanley I. Ornstein and David Ley
Richard L. Douglass
IV. Current Concepts in the Diagnosis of Alcoholism
Overview James A. Halikas Detection, Assessment, and Diagnosis of Alcoholism: Current Techniques
Types and Phases of Alcohol Dependence Illness Neuropsychology of Alcoholism: Etiology, Phenomenology, Process, and
James A. Halikas, Section Editor
GeorgeR. Jacobson
Wallace Mandell
Outcome Ralph E. Tarter and Christopher M. Ryan
Volume 2
I. Experimental Social and Learning Models of Drinking
Overview Alfonso Paredes A Conditioning Model of Alcohol Tolerance Social Models of Drinking Behavior in Animals: The Importance of Individual
Social Correlates of Drinking in Contrived Situations
Alcohol-Ingestive Habits: The Role of Flavor and Effect
Commentary on the Utility of Experimental Social and Learning Models of
Alfonso Paredes, Section Editor
Christine L. Melchior and Boris Tabakoff
Differences
Jenuine Hopper
W. Rusiniak, and John Garcia
AlcoholismThomas Stanitis
Gaylord D. Ellison and Allen D. Potthoff Alfonso Paredes and Carolyn
Jack E. Sherman, Kenneth
Frank A. Halloway, O.H. Rundell, Pamela S. Kegg, Dick Gregory, and
II. Alcohol and the Liver: Recent Developments in Preclinical and Clinical
Overview Charles S. Lieber Alcohol-Induced Liver Injury: The Role of Oxygen
Hypermetabolic State and Hypoxic Liver Damage Commentary on the Hypermetabolic State and the Role of Oxygen in Alcohol-
Alcohol-Induced Mitochondrial Changes in the L iver Effect of Ethanol on Hepatic Secretory Problems
Use of Colchicine and Steroids in the Treatment of Alcoholic Liver Disease
Research Richard A. Deitrich, Section Editor
Ronald G. Thurman, Sungchul
Yedy Israel and Hector Orrego Ji, and John J. Lemasters
Induced Liver Injury Esteban Mezey Ellen R. Gordon
Dean J. Tuma and Michael E Sorrell
Galambos and Stan P. Riepe John T.
Contents of Previous Volumes 439
III. Aging and Alcoholism
Overview Edward Gottheil Neurobiological Relationships between Aging and Alcohol Abuse Alcohol Consumption and Premature Aging: A Critical Review
Aging and Alcohol Problems: Opportunities for Socioepidemiological
Life Stressors and Problem Drinking among Older Adults
Cross-Cultural Aspects of Alcoholism in the Elderly
Edward Gottheil, Section Editor
Gerhard Freund Christopher Ryan
and Nelson Butters
Research Richard L. Douglass
Rudolf H. Moos John W. Finney and
Joseph Westermeyer
IV. Contributions from Anthropology to the Study of Alcoholism
Overview Linda A. Bennett Ethnohistory and Alcohol Studies Social-Network Considerations in the Alcohol Field Alcohol Use in the Perspective of Cultural Ecology Selected Contexts of Anthropological Studies in the Alcohol Field:
Family Research and Alcoholism Alcoholism-Treatment-Center-Based Projects Jack O. Waddell Cross-Cultural Studies of Alcoholism
Linda A. Bennett, Section Editor
Thomas W. Hill Carl A. Maida
Andrew J. Gordon
Introduction Dwight B. Heath Joan Ablon
Dwight B. Heath
Volume 3
I. High-Risk Studies of Alcoholism Overview Donald W. Goodwin Behavioral Effects of Alcohol in Sons of Alcoholics The EEG in Persons at Risk for Alcoholism
Psychopathology in Adopted-Out Children of Alcoholics: The Stockholm Adoption C. Robert Cloninger, Michael Bohman, Soren Sigvardsson, and Arne-Lils von
Donald W. Goodwin, Section Editor
Marc A. Shuckit Jan Volavka, Vicki Pollock, William F.
Gabrielli, Jr., and Sarnof A. Mednick
StudyKnorring
Premorbid Assessment of Young Men at Risk for Alcoholism Minimal Brain Dysfunction and Neuropsychological Test Performances in Offspring
Victor M. Hesselbrock, James R. Stabenau, and Michie N. Hesselbrock
Joachim Knop
of Alcoholics
II. Prostaglandins, Leukotrienes, and Alcohol Overview Erik ÄnggårdSynthesis of Prostaglandins and Leukotrienes: Effects of Ethanol
Richard A. Deitrich, Section Editor
Robert C. Murphy and Jay Y. Westcott
440 Contents of Previous Volumes
Biochemical Interactions of Ethanol with the Arachidonic Acid Cascade
Brain Arachidonic Acid Metabolites: Functions and Interactions with Ethanol Jay Y.
Sam N. Pennington
Westcott and Alan C. Collins
III. Cardiovascular Effects of Alcohol AbuseOverview David H. Van Thiel Alcohol, Coronary Heart Disease, and Total Mortality
Alcohol Consumption and Cardiovascular Risk Factors
Myocardial Effects of Alcohol Abuse: Clinical and Physiologic
Biochemical Mechanisms Responsible for Alcohol-Associated
David H. Van Thiel, Section Editor
Ronald E. LaPorte, Jane A.
Katherine M. Flegal and Cauley, Lewis H. Kuller, Katherine Flegal, and David Van Thiel
Jane A. Cauley
Consequences
Myocardiopathy
David H. Van Thiel and Judith S. Gavaler
David H. Van Thiel, J.S. Gavaler, and D. Lehotay
IV. Cerebral Functioning in Social DrinkersOverview Elizabeth Parker The Continuity Hypothesis: The Relationship of Long-Term Alcoholism to the
The Impact of Fathers’ Drinking on Cognitive Loss among Social
Alcohol Use and Cognitive Functioning in Men and Women College
Elizabeth Parker, Section Editor
Wernicke-Korsakoff Syndrome
Drinkers
StudentsA. Quitoriana, Annette M. Butler, and Lawrence A. Meredith
CT Demonstration of the Early Effects of Alcohol on the Brain Cognitive Deficits and Morphological Cerebral Changes in a Random Sample of
Brain Damage in Social Drinkers? Reasons for Caution
Statistical Issues for Research on Social Drinkers Functional Brain Imaging
Nelson Buffers and Jason Brandt
Elizabeth A. Parker, Douglas A. Parker, and Jacob A. Brody
RoseannHannon, Charles P. Butler, CarolLynn Day, StevenA. Khan, Lupo
Lesley Ann Cala
Social Drinkers Hans Bergman
Christopher Ryan Shirley Y. Hill and
Ronald Schoenberg Robert M. Kessler
Volume 4
I. Combined Alcohol and Drug Abuse Problems Overview Edward Gottheil Multiple Drug Use: Epidemiology, Correlates, and Consequences
Mechanisms of Depressant Drug Action/Interaction Sedative Drug Interactions of Clinical Importance Treating Multiple Substance Abuse Clients
Edward Gottheil, Section Editor
Richard R. Clayton
Eugene P. Schoener Paul Cushman, Jr.
Jerome F.X. Carroll
Contents of Previous Volumes 441
II. Typologies of AlcoholicsOverviewClassification and Forms of Inebriety: Historical Antecedents of Alcoholic
Thomas F. Babor and Richard J. Lauerman Empirically Derived Classifications of Alcohol-Related Problems
An Examination of Selected Typologies: Hyperactivity, Familial, and Antisocial
Alcoholic Typologies: A Review of Empirical Evaluations of Common Classification
Alcoholic Subtypes Based on Multiple Assessment Domains: Validation against
Thomas F. Babor and Roger E. Meyer, Section Editors Thomas F. Babor and Roger E. Meyer
Typologies
and Harvey A. Skinner
Alcoholism
Schemes Michie N. Hesselbrock
Treatment Outcome
Leslie C. Morey
Arthur I. Alterman and Ralph E. Tarter
Dennis M. Donovan, Daniel R. Kivlahan, and R. Dale Walker
III. The Alcohol Withdrawal Syndromes Overview Alfonso Paredes The Alcohol Withdrawal Syndrome: A View from the Laboratory
Clinical Neuroendocrinology and Neuropharmacology of Alcohol
Clinical Assessment and Pharmacotherapy of the Alcohol Withdrawal
Special Aspects of Human Alcohol Withdrawal
Alfonso Paredes, Section Editor
Dora B. Goldstein
Withdrawal
Syndrome
Wilkins
Jeffrey N. Wilkins and David A. Gorelick
Claudio A. Naranjo and Edward M. Sellers David A. Gorelick and Jeffrey N.
IV. Renal and Electrolyte Consequences of Alcohol Abuse
Overview David H. Van Thiel Disorders of the Serum Electrolytes, Acid-Base Balance, and Renal Function in
Urinary Tract Infections and Renal Papillary Necrosis in Alcoholism
Disorders of Divalent Ions and Vitamin D Metabolism in Chronic
The Pathogenesis of Renal Sodium Retention and Ascites Formation in Laennec’s
David H. Van Thiel, Section Editor
Alcoholism
Pitts and David H. Van Thiel
Alcoholism
Cirrhosis Thomas O. Pitts
Thomas O. Pitts and David H. Van Thiel Thomas O.
Thomas O. Pitts and David H. Van Thiel
Volume 5
I. Alcohol and Memory Henri Begleiter, Section Editor Overview Henri Begleiter The Chronic Effects of Alcohol on Memory: A Contrast between a Unitary and Dual
System Approach D. Adrian Wilkinson and Constantine X. Poulos
442 Contents of Previous Volumes
The Etiology and Neuropathology of Alcoholic Korsakoff’s Syndrome: Some
Cognitive Deficits Related to Memory Impairments in Alcoholism
Specificity of Memory Deficits in Alcoholism Ethanol Intoxication and Memory: Recent Developments and New
Evidence for the Role of the Basal Forebrain
Berman and Ronald J. Ellis
David P. Salmon and Nelson Butters Marlene Oscar-
Walter H. Riege
Directions Richard G. Lister, Michael J. Eckardt, and Herbert Weingartner
II. Alcohol Treatment and Society
Overview Robin Room Inebriety, Doctors, and the State: Alcoholism Treatment Institutions before
Sociological Perspectives on the Alcoholism Treatment Literature since
The Social Ecology of Alcohol Treatment in the United States The Great Controlled-Drinking Controversy
Robin Room, Section Editor
1940
1940
Jim Baumohl and Robin Room
Normal Giesbrecht and Kai Pernanen Connie Weisner
Ron Roizen
III. The Effects of Ethanol on Ion Channels
Overview Richard A. Deitrich Calcium Channels: Interactions with Ethanol and Other Sedative-Hypnotic
Effects of Ethanol on the Functional Properties of Sodium Channels in Brain Michael J. Mullin and Walter A. Hunt
Involvement of Neuronal Chloride Channels in Ethanol Intoxication, Tolerance, and
The Effects of Ethanol on the Electrophysiology of Calcium Channels
The Electrophysiology of Potassium Channels
Richard A. Deitrich, Section Editor
Drugs Steven W. Leslie
Synaptosomes
Dependence
and S.G. Oakes
Andrea M. Allan and R. Adron Harris R.S Pozos
Peter L. Carlen
IV. Hazardous and Early Problem Drinking
Overview Alfonso Paredes Studying Drinking Problems Rather than Alcoholism Social Drinking as a Health and Psychosocial Risk Factor: Anstie’s Limit
Methods of Intervention to Modify Drinking Patterns in Heavy Drinkers
Techniques to Modify Hazardous Drinking Patterns William R. Miller Alcohol-Related Hazardous Behavior among College Students
Alfonso Paredes, Section Editor
Dan Cahalan
Revisited
Kristenson
Thomas E Babor, Henry R. Kranzler, and Richard L. Lauerman Hans
Jerome Rabow, Carole A. Neuman, Ronald K. Watts, and Anthony C.R. Hernandez
Contents of Previous Volumes 443
Volume 6
I. Substance Abuse and Posttraumatic Stress Disorder
Overview Edward Gottheil Posttraumatic Stress Disorder and Substance Abuse: Clinical Issues The Interrelationship of Substance Abuse and Posttraumatic Stress Disorder:
Edward Gottheil, Section Editor
Edgar P. Nace
Terence M. Keane, Robert J. Gerardi,Epidemiological and Clinical Complications Judith A. Lyons, and Jessica Wolfe
Abuse
for Posttraumatic Stress Disorder and Substance Use Disorder Robert F. Peck, Ralph Robinowitz, William Bell, and Dolores Little
Alcohol Dependency
Biological Mechanisms in Posttraumatic Stress Disorder: Relevance for Substance
Coping and Defending Styles among Vietnam Combat Veterans Seeking Treatment Walter E. Penk,
Thomas R. Kosten and John Krystal
Posttraumatic Stress Disorder in World War II and Korean Combat Veterans with Keith A. Druley and Steven Pashko
II. Alcohol and Its Management in the Workplace Overview Paul M. Roman The Epidemiology of Alcohol Abuse among Employed Men and Women
A. Parker and Gail C. Farmer Growth and Transformation in Workplace Alcoholism Programming Constructive Confrontation and Other Referral Processes
Identification of Alcoholics in the Workplace
Monitoring the Process of Recovery: Using Electronic Pagers as a Treatment
Posttreatment Follow-up, Aftercare, and Worksite Reentry of the Recovering
New Occupations and the Division of Labor in Workplace Alcoholism
Paul M. Roman, Section Editor
Douglas
Paul M. Roman Harrison M. Trice and
William J. Sonnenstuhl
and Lynn Gracin
Intervention William J. Filstead
Alcoholic Employee
Programs Terry C. Blum
Walter Reichman, Douglas W. Young,
Andrea Foote and John C. Erfurt
III. Consequences of Alcohol Abuse Unique to Women
Overview David H. Van Thiel Effects of Moderate Consumption of Alcoholic Beverages on Endocrine Function in
Effects of Alcohol Abuse on Reproductive Function in Women Maternal Ethanol Use and Selective Fetal Malnutrition
Ethanol Metabolism and Hepatotoxicity: Does Sex Make a Difference?
David H. Van Thiel, Section Editor
Postmenopausal Women: Bases for Hypotheses Judith S. Gavaler Nancy K. Mello
Stanley E. Fisher and Peter I. Karl
Van Thiel and Judith A. Gavaler David H.
444 Contents of Previous Volumes
IV. Markers for Risk of Alcoholism and Alcohol Intake
Overview Richard A. Deitrich Physiological and Psychological Factors as Predictors of Alcoholism Risk
Brain Evoked Potentials as Predictors of Risk
Molecular Markers for Linkage of Genetic Loci Contributing to Alcoholism
Blood Markers of Alcoholic Liver Disease Discriminant Function Analysis of Clinical Laboratory Data: Use in Alcohol
Acetaldehyde and Its Condensation Products as Markers of Alcoholism
Richard A. Deitrich, Section Editor
Marc A.Shuckit
Nagamoto
Goldman
Robert Freedman and Herbert
David
Charles S. Lieber
Research
A. Collins
Zelig S. Dolinsky and Jerome M. Schnitt Michael
Volume 7: Treatment Research
I. Alcoholics Anonymous: Emerging Concepts Overview Chad D. Emrick A Sociocultural History of Alcoholics Anonymous
Alcoholics Anonymous: Membership Characteristics and Effectiveness as
Some Limitations of Alcoholics Anonymous Alcoholics Anonymous and Contemporary Psychodynamic Therapy
Al-Anon and Recovery
Chad D. Emrick, Section Editor
Harrison M. Trice and William J.Staudenmeier, Jr.
Treatment Chad D. Emrick Alan C. Ogborne
Edward J. Khantzian and John E. Mack
Timmen L. Cermak
II. Family Systems and Family Therapy in Alcoholism
Overview Edward Gottheil Family, Alcohol, and Culture Alcoholism and Family Interaction Alcoholism and Family Factors: A Critical Review Outcomes of Family-Involved Alcoholism Treatment
Edward Gottheil, Section Editor
Linda A. Bennett Theodore Jacob and Ruth Ann Seilhamer
Barbara S. McCrady Jane Jacobs and Steven J. Wolin
III. Serotonin and Alcohol PreferenceOverview Richard A. Deitrich Serotonin and Ethanol Preference
Richard A. Deitrich, Section Editor
William J. McBride, James M. Murphy, Lawrence Lumeng, and Ting-Kai Li
Contents of Previous Volumes 445
Use of Serotonin-Active Drugs in Alcohol Preference Studies Serotonin Uptake Blockers and Voluntary Alcohol Consumption: A Review of Recent
Joseph E. Zabik
Studies Kathryn Gill and Z. Amit
IV. Clinical Pharmacology in the Treatment of Alcohol Dependence: Manipulation
Overview Alfonso Paredes Serotonin Uptake Inhibitors Attenuate Ethanol Intake in Problem Drinkers
Serotonin Uptake Blockers and the Treatment of Alcoholism Benzodiazepines in the Treatment of Alcoholism
Does Lithium Carbonate Therapy for Alcoholism Deter Relapse Drinking?
Treatment of Chronic Organic Mental Disorders Associated with Alcoholism
Methodological and Ethical Issues in Alcohol Research
of Neurobehavioral Mechanisms of Drinking Alfonso Paredes, Section Editor
ClaudioA. Naranjo and Edward M. Sellers
David A. Gorelick David Nutt, Bryon Adinof, and
Markku Linnoila
C. Clark and Jan Fawcett
R. Martin, Michael J. Eckardt, and Markku Linnoila
David
Peter
Alfonso Paredes
Volume 8: Combined Alcohol and Other Drug Dependence
I. The Nature of the Syndrome The Behavioral Pharmacology of Alcohol and Other Drugs: Emerging
The Dependence Syndrome Concept as Applied to Alcohol and Other Substances of
Operationalization of Alcohol and Drug Dependence Criteria by Means of a
From Basic Concepts to Clinical Reality: Unresolved Issues in the Diagnosis of
Thomas F. Babor, Section Editor
Issues
Abuse
Structured Interview
DependenceJoseph Brown
Marilyn E. Carroll, Maxine L. Stitzer, Eric Strain, and RichardA. Meisch
Therese A. Kosten and Thomas R. Kosten
Linda B. Cottler and Susan K. Keating
Thomas F. Babor, Barbara Orrok, Neil Leibowitz, Ronald Salomon, and
II. Social Deviancy and Alcohol Dependence
A Review of Correlates of Alcohol Use and Alcohol Problems in Adolescence Kathleen K. Bucholz
Drug Use and Its Social Covariates from the Period of Adolescence to YoungAdulthood: Some Implications from Longitudinal Studies
Longitudinal Patterns of Alcohol Use by Narcotics Addicts M. Douglas Anglin, and Keiko Powers
Problem Drinking and Alcohol Problems: Widening the Circle of Covariation Stanley W. Sadava
Alfonso Paredes, Section Editor
Kazuo Yamaguchi Yih-Ing Hser,
446 Contents of Previous Volumes
111. Biological Issues: Ethanol-Drug Interactions
Behavioral Aspects of Alcohol-Tobacco Interactions Interactions of Ethanol and Nicotine at the Receptor Level Interactions between Alcohol and Benzodiazepines
Richard A. Deitrich, Section Editor
James P. Zacny
Leo E. Hollister Allan C. Collins
IV. Emerging Clinical Issues in the Treatment of Alcohol and/or Other Drugs of
Cultural Factors in the Choice of Drugs Self-Regulation and Self-Medication Factors in Alcoholism and the Addictions:
Treating Combined Alcohol and Drug Abuse in Community-Based
Structured Outpatient Treatment of Alcohol vs. Drug Dependencies Arnold M.
Behavioral Treatment of Alcohol and Drug Abuse: What Do We Know and Where
Abuse Edward Gottheil, Section Editor
Dwight B. Heath
Similarities and Differences E.J. Khantzian
Programs Robert L. Hubbard
Washton
Shall We Go? Reid K. Hester, Ted D. Nirenberg, and Ann M. Begin
Volume 9: Children of Alcoholics
I. Genetic Predisposition to Alcoholism
Overview Henri Begleiter A Longitudinal Study of Children of Alcoholics Neuropsychological Factors in Individuals at High Risk for Alcoholism
Hesselbrock, Lance O. Bauer, Michie N. Hesselbrock, and Robert Gillen Potential Biochemical Markers for the Predisposition toward Alcoholism
Eskay and Markku Linnoila Neurophysiological Factors in Individuals at Risk for Alcoholism
and Henri Begleiter Developmental Behavior-Genetic Perspective of Alcoholism Etiology
Tarter
Henri Begleiter, Section Editor
Marc A. Schuckit Victor
Robert
Bernice Porjesz
Ralph E.
II. Fetal Alcohol Syndrome
Overview Donald M. Gallant Basic Animal Research A Revised Estimate of the Economic Impact of Fetal Alcohol Syndrome
Clinical Correlations between Ethanol Intake and Fetal Alcohol Syndrome
Donald M. Gallant, Section Editor
Stata Norton and Lois A. Kotkoskie Ernest L.
ClaireAbel and Robert J. Sokol
B. Ernhart
Contents of Previous Volumes 447
The Effects of Prenatal Alcohol on the Central Nervous System Kathy J. Smith and
Multilevel Intervention for Prevention of Fetal Alcohol Syndrome and Effects of Michael J. Eckardt
Prenatal Alcohol Exposure Iris E. Smith and Claire D. Coles
III. Vulnerability to Disease in Relatives of Alcoholics
Overview David H. Van ThielVulnerability to Alcoholic Liver Disease
H. Van Thiel Hepatic Encephalopathy Coexistent with Alcoholism
Arria, and David H. Van Thiel Vulnerability to Cardiac Disease
David H. Van Thiel, Section Editor
Amelia M. Arria, Ralph E. Tarter, and David
Ralph E. Tarter, Amelia M.
Samir Zakhari
IV. Social and Environmental Issues
OverviewAdult Children of Alcoholics: The History of a Social Movement and Its Impact on
Epidemiological Perspectives on Children of Alcoholics
Psychological Characteristics of Children of Alcoholics: Overview of Research
From Prevention to Treatment: Issues for School-Aged Children of James G. Emshoff and Lisa L. Anyan
Treating Adults Raised by Alcoholic Parents
Edward Gottheil and Jeannette L. Johnson, Section Editors
Edward Gottheil and Jeannette L. Johnson
Clinical Theory and Practice
Theodore Reich
Methods and Findings
Alcoholics
Stephanie Brown Stephen H. Dinwiddie and
Kenneth J. Sher
Jeannette L. Johnson and Stuart Tiegel
Volume 10: Alcohol and Cocaine
Alfonso Paredes, Section Editor I. Clinical Pathology Overview Alfonso Paredes The Role of Alcohol in Cocaine Dependence
Alcohol and Cocaine: Clinical and Pharmacological InteractionsHypothalamic–Pituitary Function during Alcohol Exposure and Withdrawal and
Jeffrey N. Wilkins, David A. Gorelick, Koonlawee Nademanee,
Hari Khalsa, Alfonso Paredes, and M. Douglas Anglin
David A. Gorelick
Cocaine Exposure Anna Taylor, and David S. Herzberg
Disorders
McKenna and Alfonso Paredes
Emergency Room Evaluation of Cocaine-Associated Neuropsychiatric
Dual-Diagnosis Empirical and Developmental-Humanistic Approaches Ricardo Mendoza, Bruce L. Miller, and Ismael Mena
Alina M.
448 Contents of Previous Volumes
II. Psychosocial Factors and Treatment Overview Edward Gottheil Alcohol and Cocaine Abuse: A Comparison of Epidemiology and Clinical
Prohibition or Liberalization of Alcohol and Drugs? A Sociocultural
A Comparison of Drug Conditioning and Craving for Alcohol and Cocaine
Psychotherapy and Patient Needs in the Treatment of Alcohol and Cocaine Robert J. Schneider and Edward J. Khantzian
Acute Treatment of Alcohol and Cocaine Emergencies
Edward Gottheil, Section Editor
Characteristics
Perspective Dwight B. Heath
B. Newlin
Abuse
Andrew E. Slaby
Mary H. Closser and Thomas R. Kosten
David
Wanda A. Taylor and
III. Pharmacology and Biochemistry Overview Donald M. GallantNeuropharmacology of Cocaine and Ethanol Dependence
Recent Advances in Pharmacological Research on Alcohol: Possible Relations with
Molecular Mechanisms Associated with Cocaine Effects: Possible Relationships with Mary C. Ritz, Michael J. Kuhar, and Frank R. George
Developing and Evaluating New Treatments for Alcoholism and Cocaine
Donald M. Gallant, Section Editor
George E Koob and Friedbert Weiss
Cocaine
Effects of Ethanol
DependenceThomas McLellan
Krystyna M. Wozniak and Markku Linnoila
Charles P. O’Brien, Arthur Alterman, Anna Rose Childress, and A.
IV. Medical Complications of Alcohol and Cocaine Abuse
Overview David H. Van Thiel Gastrointestinal Complications of Cocaine Abuse
Hepatotoxicity Associated with Cocaine Abuse
Cardiovascular Complications of Cocaine Abuse Respiratory Complications of Cocaine Abuse
David H. Van Thiel, Section Editor
David H. Van Thiel and Joshua A. perper
perperDavid H. Van Thiel and Joshua A.
Joshua A. perper and David H. Van Thiel Joshua A. Perper and David H. Van Thiel
Volume 11: Ten Years of Progress
I. Social and Cultural Perspectives Overview Dwight B. Heath Sociology Helene Raskin White Anthropology Dwight B. Heath
Dwight B. Heath, Section Editor
Contents of Previous Volumes 449
Psychology Marsha E. Bates Children and Alcohol Family Systems Gender Issues Ethnicity Howard T. Blane The Workplace Public Drinking Eric Single Substance and Symbol
Alan R. Lang and Werner G.K. Stritzke Linda A. Bennett and Michael LaBonte
Edith S. Lisansky Gombert
Craig R. lanes and Genevieve M. Ames
Howard F.Stein
II. Physiology and Biochemistry Overview Richard A. Deitrich Neuronal Ion Channels Opioid Peptides The Liver David W. Crabb Genetic Transmission David Goldman Immunological Aspects
Richard A. Deitrich, Section Editor
Enrico Sanna and R. Adron Harris Janice C. Froehlich and T.K. Li
Rodney C. Baker and Thomas R. Jerrells
III. Clinical Pathology Overview Alfonso Paredes Biobehavioral Correlates Typologies in Women Reducing the Desire to Drink: Pharmacology to Neurobiology
Molecular Biology and Behavior
Alfonso Paredes, Section Editor
David V. Gauvin, Eme Y. Cheng, and Frank A. Holloway Sara Jo Nixon
Ray Z. Litten and John P. Allen
Ernest P. Noble and Alfonso Paredes
IV. Trends in Treatment Overview Edward Gottheil Developments in Alcoholism Treatment Behavioral Treatment Pharmacological Treatment David M. Gorelick Inpatient Treatment Edward P. Nace Psychodynamic Approaches Dealing with Alcohol Problems in the Workplace
Edward Gottheil, Section Editor
Laura Schmidt and Constance Weisner Dennis M. Donovan and G. Alan Marlatt
Nancy Boehm, E.J. Khantzian, and Lance M. Dodes Paul M. Roman and Terry C. Blum
Volume 12: Alcoholism and Women
I. Epidemiology OverviewVulnerability to Alcoholism in Women: Genetic and Cultural Factors
May C. Dufour and Richard F. Fuller, Section Editors May C. Dufour and Richard K. Fuller
Shirley Y. Hill
450 Contents of Previous Volumes
Drinking and Problem Drinking in US Women: Patterns and Recent Sharon C. Wilsnack and Richard W. Wilsnack
Older Women and Alcohol: Use and Abuse Violent Victimization among Women with Alcohol Problems
Women, Alcohol, and Driving Employed Women with Alcohol Problems Who Seek Help from Employee Assistance
TrendsEdith S. Lisansky Gomberg
Brenda A. Miller and William R. Downs
Patricia F. Waller and Frederic C. Blow
Programs: Description and Comparisons Eileen M. Harwood
Terry C. Blum, Paul M. Roman, and
II. Physiology Overview Richard A. Deitrich Gender Differences in Alcohol Metabolism: Physiological Responses to
Ethanol Holly S. Thomasson Mental and Physical Health Consequences of Alcohol Use in Women
HillAlcohol Effects on Hormone Levels in Normal Postmenopausal Women and in
Postmenopausal Women with Alcohol-Induced Cirrhosis Gender Differences in Animal Studies: Implications for the Study of Human
Alcoholism Francine E. Lancaster Sex Distinctiveness in Effectiveness Genotype Sex Differences in Ethanol-Related Behaviors in Genetically Defined Murine
Sex Differences in Mesolimbic Dopamine Responses to Ethanol and Relationship to
Anxiolytic Effects of Steroid Hormones during Estrous Cycle: Interactions with Michelle D. Brot, George F. Koob, and Karen T. Britton
Richard A. Deitrich, Section Editor
Shirley Y.
Judith S. Gavaler
Gerald E. McClearn
Stocks
Ethanol Intake in Rats
Ethanol
Byron C. Jones and Keith E. Whitfield
BettyA. Blanchard and Stanley D. Glick
III. Behavior and Treatment Issues Overview Alfonso Paredes Women, Alcohol, and Sexuality Cognitive Psychosocial Performance and Recovery in Female Alcoholics
The Emergence of Problem-Drinking Women as a Special Population in Need of
Alfonso Paredes, Section Editor
Linda J. Beckman and Kimberly T. Ackerman Sara Jo
Nixon and Susan Wagner Glenn
Treatment Laura Schmidt and Constance Weisner
IV. Social and Cultural Issues OverviewRace/Ethnicity and Other Sociocultural Influences on Alcoholism Treatment for
WomenPatterns of Alcohol Use among Ethnic Minority Adolescent Women Ruth W.
Edwards, Pamela Jumper Thurman, and Fred Beauvais
Edward Gottheil and Ellen E Gottheil, Section Editors Edward Gottheil and Ellen E Gottheil
Beatrice A. Rouse, James H. Carter, and Sylvia Rodriguez-Andrew
Contents of Previous Volumes 451
Alcoholism in the Family: A Multicultural Exploration Gender Differences for the Risk of Alcohol-Related Problems in Multiple National
Andrea C. Barthwell
Contexts: A Research Synthesis from the Collaborative Alcohol-RelatedLongitudinal Report E. Victor Leino, Carlisle Shoemaker, Catherine R. Ager, and Heidi P. Ferrer
Kaye Middleton Fillmore, Jacqueline M. Golding, Steven Kniep,
Volume 13: Alcohol and Violence
I. Epidemiology Richard K. Fuller, Section Editor Overview Richard K. Fuller Epidemiological Issues in Alcohol-Related Violence The Relationship of Alcohol to Injury in Assault Cases
Alcohol and Spouse Abuse: Ethnic Differences Longitudinal Perspectives on Alcohol Use and Aggression during
Alcohol and Violence-Related Injuries in the Emergency Room
Judith Roizen Susan Ehrlich Martin and
Ronet Bachman Glenda Kaufman Kantor
Adolescence Helene Raskin White Cheryl J. Cherpitel
II. Neurobiology Overview Richard A. Deitrich Emerging Themes in Preclinical Research on Alcohol and Aggression
D. Caroline Blanchard, J. Andy Henrie, and Robert J. Blanchard Alcohol, GABAA–Benzodiazepine Receptor Complex, and Aggression
Miczek, Joseph F.DeBold, Annemoon M.M. van Erp, and Walter Tornatzky Serotonin in Early-Onset Alcoholism A Nonhuman Primate Model of Excessive Alcohol Intake: Personality and
Richard A. Deitrich, Section Editor
Errol Yudko,
Klaus A.
Matti Virkkunen and Markku Linnoila
Neurobiological Parallels of Type I- and Type II-Like Alcoholism and Markku Linnoila
J. Dee Higley
III. Psychology Overview Alfonso Paredes Effects of Alcohol on Human Aggression: Validity of Proposed Explanations
Is There a Causal Relationship between Alcohol and Violence? A Synthesis of
Alcohol and Cocaine Interactions and Aggressive Behaviors
Alfonso Paredes, Section Editor
BradJ. Bushman
Evidence
Alfonso Paredes, and Jenia Bober Booth
Mark W. Lipsey, David B. Wilson, Mark A. Cohen, and James H. Derzon M.Elena Denison,
IV. Family Issues Overview
Edward Gottheil and Ellen F. Gottheil, Section Editors Edward Gottheil and Ellen E Gottheil
452 Contents of Previous Volumes
When Women Are under the Influence: Does Drinking or Drug Use by Women Glenda Kaufman Kantor and Nancy Asdigian
How Far Have We Come? A Critical Review of the Research on Men Who
Alcohol, Drugs, and Violence in Children’s Lives
Issues in the Linkage of Alcohol and Domestic Violence Services
Provoke Beatings by Men?
Batter
and William R. Downs
Larry A. Kroutil, E. Joyce Roland, and Marlee Moore-Gurrera
W. Vernon Lee and Stephen P. Weinstein Brenda A. Miller, Eugene Maguin,
James J. Collins,
Volume 14: The Consequences of Alcoholism
I. Medical Consequences of AlcoholismOverview Charles S. Lieber Metabolism of Ethanol and Some Associated Adverse Effects on the Liver and the
Alcohol and the Pancreas Alcohol and Cancer Alcohol and Lipids Cardiovascular Effects of Alcohol
Charles S. Lieber, Section Editor
Stomach Charles S. Lieber and Maria A. Leo Steven Schenker and Ruth Montalvo
Helmut K. Seitz, Gudrun Pöschl, and Ulrich A. SimanowskiEnrique Baraona and Charles S. Lieber
Howard S. Friedman
II. Neuropsychiatric Consequences of Alcoholism
OverviewMechanisms of Alcohol Craving and Their Clinical Consequences
A Review of the Effects of Moderate Alcohol Intake on Psychiatric and Sleep
Edward Gottheil and Ellen E Gottheil, Section Editors
Edward Gottheil and Ellen F. Gottheil Edward G.
Singleton and David A. Gorelick
DisordersLaurence Westreich
Howard B. Moss
System
Disorders
Ricardo Castaneda, Norman Sussman, Robert Levy, Mary O’Malley, and
Peter R. Giancola and Executive Cognitive Functioning in Alcohol Use Disorders
Brain Imaging: Functional Consequences of Ethanol in the Central Nervous
Complications of Severe Mental Illness Related to Alcohol and Drug Use David Lyons, Christopher T. Whitlow, Hilary R. Smith, and Linda J. Porrino
Robert E. Drake and May F. Brunette
III. Economic Consequences of AlcoholismOverview Richard K. Fuller Economic Costs of Alcohol Abuse and Alcoholism
Fountain, and Gina Livermore The Effects of Price on the Consequences of Alcohol Use and Abuse
Chaloupka, Michael Grossman, and Henry Saffer
Richard K. Fuller, Section Editor
Henrick J. Harwood, Douglas
Frank J.
Contents of Previous Volumes 453
Drinking, Problem Drinking, and Productivity The Cost Offsets of Alcoholism Treatment
John Mullahy and Jody Sindelar Harold D. Holder
IV. An International Perspective on the Biobehavioral Consequences of
Overview Alfonso Paredes Experience with the Alcohol Use Disorders Identification Test (AUDIT) in
Elena Medina-Mora, Silvia Carreño, and Juan Roman De la Fuente Problems Associated with Hazardous and Harmful Alcohol Consumption in
Carlos Campillo, Martha Romero, Gabriela Saldivar, and Luciana Ramos Sanctification of “The Accursed”: Drinking Habits of the French Existentialists in the
Cocaine Metabolism in Humans after Use of Alcohol: Clinical and Research
Alcoholism Alfonso Paredes, Section Editor
Mexico
Mexico
1940s Tiina Arppe
Implicationsdel la Torre
Hepatocellular Carcinoma Kamada
Jordi Camí, Magi Farré, Maria Luisa González, Jordi Segura, and Rafael
Interrelationship between Alcohol Intake, Hepatitis C, Liver Cirrhosis, and Harumasa Yoshihara, Katsuhisa Noda, and Takenobu
Index
Abstainers, definition of, 397 Abstinence management, 367 Access to alcoholism treatment
Administrative agents (cont.)and treatment protocol, 38–39 types of, 27–28
and behavioral health managed care organiza-
and definitions of need, 108–111 and form of treatment, 111–113 and gatekeeping, 117–121 patient placement criteria, 157–171 political factors, 123–124 Affiliation level societal factors, 122–124
Administrative burden, meaning of, 59–60 Adolescent Diagnostic Interview (ADI), 310 Adolescents. See also Alcohol treatment for ado-
tion (BHMCO) definitions, 109–110
lescentspatient placement criteria, 168
Adverse selection, 239
and access to substance abuse treatment, 143,
of treatment facilities, 12 African Americans, barriers to treatment, 167–168 Aftercare. See Continuing care
and treatment–seekers, 114–117 151–152 Access to Community Care and Effective Services
and Supports (ACCESS) program, 79, 82 Access to substance abuse treatment
and affiliation level, 143, 151–152 Agein national substance abuse treatment system, and patient placement criteria, 166
and substance abuse treatment, 244
(AHRQ), research projects of, 203
144–146and ownership of facility, 142,150 relapse prevention, 147–148 in rural areas, 177–192 self–help, 147–148support services, 148 and treatment setting, 142, 148–150 and type of care, 141–142, 146–147
Agency for Health Care Research and Quality
Alanine aminotransferase (ALT), 401 Al-Anon, 333–334. See also Alcoholics AnonymousAl-Anon Facilitation Therapy (AFT), 334
group therapy based on, 334 referral, effects of, 333–334
definition of, 108 Access to treatment. See also Access to alcoholism
treatment; Access to substance abuse treat- ment lifetime prevalence, 157
for adolescents, 308–311
Alcohol abuse
definition of, 143–144 improving access with patient placement crite-
Alcohol abuse screening
ria, 168–171 AUDIT, 399–401and managed care, 119–121, 426–427 CAGE, 394, 397–399patient perception of, 183–185 and uninsured, 112
Accreditation, of treatment facilities, 12, 36–37 Administrative agents
laboratory tests, 401Alcohol behavioral marital therapy (ABMT), 344Alcohol dependence, definition of, 108Alcohol and Drug Services Study (ADSS)
control of treatment activities, 39–40 and network development, 38 relationship with payer, behavioral health man-
on access to services, 144–152 on information systems, 60–61
Phases I through III data, 10Alcohol-focused spouse involvement (AFSI), 344–
Alcohol treatment for adolescents
aged care organization (BHMCO), 35–37
managed care organization (BHMCO), 37–40relationship with provider, behavioral health 345
risk-sharing, 36, 42–43 behavioral therapy, 316
455
456 Index
Alcohol treatment for adolescents (cont.)brief interventions, 316 39, 100, 103 and co-occurring disorders, 319–320 developmental factors, 318 treatment, 419–433 diagnostic aspects, 308–311 environmental factors, 322 and ethnic minorities, 320 and family characteristics, 318 family therapy, 315–316 and gender, 320 health outcomes, 322–323 heterogeneity of youth population, 318–320 pharmacotherapy, 317 (AHRQ) initiatives, 100 posttreatment functioning, 321–322 prevalence of teen drinking, 307–308 relapse, 320–321 self-change efforts, 317self-help programs, 314–315, 321treatment outcome research, 311–314
American Society on Addiction Medicine (ASAM),
on impact of managed care on substance abuse
on levels of care, 159–160 Patient Placement Criteria (ASMA PPC-2), use
by substance abuse providers, 56, 58, 157–171 on transition to continuing care, 365–366
Aspartate aminotransferase (AST), 401 Assertive community treatment (ACT), 80
Association for Health Research and Quality
At-risk alcohol use, definition of, 397AUDIT, alcohol abuse screening, 399–401,408 Automobile accidents, rural areas, 188
Behavioral contract, in Behavioral Couples
Behavioral Couples Therapy (BCT), 339–345
case management models, 82
Therapy (BCT), 339–340 Alcohol use, levels of, 397 Alcohol Use Disorder Inventory Test (AUDIT), alcohol behavioral marital therapy (ABMT), 344
399–401 alcohol-focused spouse involvement, 344–345with behavioral contract, 339–340 components of, 339 Counseling for Alcoholics’ Marriages (CALM)
with disulfiram contract, 340–341 effectiveness of, 349–350 minimal spouse involvement (MSI), 344 with relationship focus, 345
questions of, 400
and adolescents, 314–315 effectiveness of, 111 Project, 340–342 and rural residents, 179 scope of use, 111
prevalence of alcohol use disorders, 395–396 screening tests for, 286 time frame and abuse, 15–16
access to. See Access to alcoholism treatment adolescents. See Alcohol treatment for adoles-
and continuing care, 357–370 economic evaluation methods, 210–226 effectiveness of, 99–100 and family therapy, 329–353 and form of alcohol use, 108–109 forms of treatment, 100, 111–113 individual factors in help-seeking, 114–117 managed care treatment setting, 393–412 measures of need, 109 pathways to treatment, 107 problem drinking/health services utilization/
Alcoholism treatment carve-outs study, 271–283
Alcoholics Anonymous (AA). See also Al-Anon
Alcoholism
Behavioral health, rationale for, 101 Behavioral health managed care organization
Alcoholism treatment (BHMCO), 28–46 administrative controls, 39–40 advantages of, 30
agent-provider relationship, 37–40 carve-outs, 32, 34, 42, 120, 238, 422–423 and conflicting treatment approaches, 28–29 cost control methods, 422 and definition of treatment need/access, 109–
development of, 30–31, 237–238 discretionary activities, 40 functional view of, 33 growth of, 422 largest organization, 109 network development, 37–38 organizational variations, 31–32 precertification/concurrent review, 38–39 quality aspects, 36–37
services provided by, 30 sources of patient coverage, 30–31
cents agent-payer relationship, 35–37
110
cost of medical care study, 285–295
analysis of findings, 280–283 methods of study, 273–274 results, 275–280 service delivery, 238
American Managed Behavioral Healthcare Asso- ciation (AMBHA), 121
Index 457
Behavioral health managed care organization Clinical Institute Withdrawal Assessment for Al-
Cocaine, time frame and abuse, 16 Cognitive deficits, and adolescent alcohol use, 314 Cognitive impairment, and patient placement, 162 Common provider network hypothesis, 89 Community-based programs
court referrals to, 14–15
(cont.) cohol, 168staff models, 422 transaction cost economics, 41–44 treatment protocols, 38–39 utilization management, 422
Behavioral marital therapy (BMT), 222–223Behavioral therapy, and adolescent alcohol use,
Benefit-cost analysis, elements of, 211 Benefit-cost studies, 212, 213, 216, 219, 220, 222–
Benefits value comparison (BVC) model, 424 Border-crossing, for access to treatment, 186 Brief Alcohol Screening and Intervention for Col-
Brief intervention, 402–410 and adolescents, 316 effectiveness of, 403–410 elements of, 402–403 goals of, 402
316 integrated models, 78–79, 82Community Mental Health Centers program, 78 Community Reinforcement Approach (CRA)
223 disulfiram contract in, 342 effectiveness of, 339
Community Reinforcement and Family Training (CRAFT), 336
lege Students (BASIC), 316 effectiveness of, 336, 338Community Support program, 78 Comorbid problem management, 367 Composite International Diagnostic Interview-
Comprehensive integrated service settings, 82 Conduct disorder, and alcohol use, 319 Confidentiality, financing of substance abuse treat-
Substance Abuse Module (CIDI-SAM), 311
Brokered model, services integration, 80, 81
CAGE, alcohol abuse screening, 394, 397–399 Capitation Consumers
ment, 243
soft capitation, 242 substance abuse treatment financing, 241–242
Carbohydrate-deficient transferrin (CDT), 401 Carve-in, health maintenance organizations
Carve-outs. See also Alcoholism treatment carve-
behavioral health managed care organization
employer-sponsored health plans, 62, 64–65,
state employee health plans, 65, 238 substance abuse treatment, 242–243
demand for treatment, 243–244 of substance abuse treatment, 243–248 types of, 232
Continuing care, 357–370 (HMOs), 32,120 abstinence management, 367
out comorbid problem management, 367
(BHMCO), 32, 34, 42, 120, 422–423
238 effectiveness of, 363–365
and causes of relapse, 366
controlled studies on, 359–363 correlational studies of, 359 criteria for transition to, 365–366
facilitation of alternative reinforcers, 367 and long-term recovery factors, 367–368 motivational enhancement therapy (MET), 367
research needs, 368–369
VA substance abuse treatment, 380–382,386–387 Contract method. See Behavioral Couples Therapy
Control mechanisms, types of, 40
Center for Substance Abuse Treatment (CSAT),
treatment improvement protocols (TIPS), 189–
Centers for Disease Control (CDC), research
100,121 and performance indicators, 369
190 therapeutic goals for, 367–368
projects of, 203 Child and Adolescent Service System program, 79 (BCT)Chronic condition, substance abuse as, 247, 248,
Cigarette smoking, and alcohol use, 314, 316 Client DATCAP, 257 Clients
369, 380–381 Co-occurring disordersand alcohol use by adolescents, 319–320 and help seeking, 115 and integrated services. See Services integrationand patient placement, 162–163 prevalence rates, 75 PTSD/substance abuse and veterans, 374, 378,
categories of, 14–15 pathways to treatment, 14–15sources of payment, 19
Clinical criteria, standardization of, 56–58 380
458 Index
Co-occurring disorders (cont.) Disability, behavioral disorders in definition, 239 Disulfiram contract in Behavioral Couples
Community Reinforcement Approach (CRA),
components of contract, 340–341 effectiveness of, 341–343
at-risk groups, 75 and women, 114–115, 162–163 Therapy, 340–341
342Coping-skills therapy, for spouses of alcoholics, 333 Cost containment methods, managed care, 191 Cost-effectiveness analysis, elements of, 210–211 Cost-effectiveness studies, 212, 213, 214, 215, 217,
Cost-minimization analysis, elements of, 210Cost minimization studies, economic evaluation
Cost-offset analysis, elements of, 211 Cost sharing, and probability of behavioral health
Cost studies, economic evaluation studies, 212,
Cost–utilityanalysis, elements of, 211Council on Accreditation of Services for Families
Counseling for Alcoholics’ Marriages (CALM)
218, 219, 221–222 Drug Abuse Reporting Program (DARP), 313Drug Abuse Screening Test (DAST-10), 286 Drug Abuse Treatment Cost Analysis Program
studies, 217 (DATCAP), 216 amendments/updates, 265–266 applications of, 257–259
treatment, 191 191 background of, 254–255 Client DATCAP, 257
216, 217, 218, 219 conceptual aspects, 255–256opportunity cost approach, 255–256resource use/cost categories in, 256
and Children (COA), 121
Project, 340–342 background of, 260
Drug Abuse Treatment Financing Analysis Pro-gram (DATFin), 260–264
conceptual aspects, 260–263parts of, 261–262 revisions to, 265 use for case studies, 263–264
disulfiram contracts, 340–342 Counselors in recovery, in addiction treatment, 59 Couples therapy. See also Family therapy
Behavioral Couples Therapy (BCT), 339–345residential couples group workshop, 348 Drug Abuse Treatment Outcome Study (DATOS),
Drug Abuse Treatment System Survey (DATSS),
Drug and Alcohol Program Treatment Inventory
Drug courts, increase in, 22–23 Drug Free Workplace Act, 30 Drug treatment, and service delivery, 23 Dual diagnosis. See Co-occurring disorders
Economic cost analysis, elements of, 210 Economic evaluation instruments, 253–266
Credentialing, definition of, 59 54,139 Criminal justice system
drug courts, 22–23 139–140as gateway to treatment, 14–15, 22–23, 188
Customary Drinking and Drug Use Record, 310
DATCAP. See Drug Abuse Treatment Cost Analy-
DATFin. See Drug Abuse Treatment Financing
Demand for treatment, from consumers, 243–244Department of Veteran Affairs (VA). See VA sub-
(DAPTI), 378
sis Program
Analysis Program
stance abuse treatment evaluation Drug Abuse Treatment Cost Analysis Program
Drug Abuse Treatment Financing Analysis Pro-Dependency theory (DATCAP), 254–259
elements of, 45 and managed care, 45–46 gram (DATFin), 260–264
Dependent alcohol use, definition of, 397 Diagnosis benefit–cost analysis, 211
Economic evaluation methods, 210–226
cost-effectiveness analysis, 210–211cost-minimization analysis, 210 cost-offset analysis, 211
(DICA), 310 cost-utility analysis, 211 economic cost analysis, 210
(DISC),310 findings/evidence in study of, 223–224full dollar value of health-related outcomes
ders (DSM-IV) method, 216future study recommendations, 224–226historical view, 211, 215
adolescent alcohol abuse, 308–311alcohol abuse screening, 286, 397–402
Diagnostic Interview for Children and Adolescents
Diagnostic Interview Schedule for Children
Diagnostic and Statistical Manual of Mental Disor-
alcohol abuse in adolescent population, 308–309substance abuse criteria, 39
Index 459
Economic evaluation studies Family therapy (cont.)benefit-cost studies, 212, 213, 216, 219, 220,
cost-effectiveness studies, 212, 213, 214, 215,
cost minimization studies, 217 cost studies, 212, 216, 217, 218, 219literature review, 212, 213 methodological studies, 213, 214, 215, 216, 217,
studies since 1995, 216–223 studies through 1994, 212–214 themes of older studies, 215
Alcoholics Anonymous (AA), 111 alcoholism treatment, 99–100patient perceptions of, 183 and services integration, 81–82
Behavioral Couples Therapy (BCT), 339–345Community Reinforcement and Family Train-
coping-skills therapy, 333effectiveness of, 337–338, 348–352Family Systems Therapy (FST), 346–347future view of, 352–353Johnson Institute Intervention, 336–337 Multisystemic Therapy (MST), 315–316Pressure to Change (PTC), 335–336 residential couples group workshop, 348 Unilateral Family Therapy (UFT), 334–335
222–223
217, 218, 219, 221–222 ing (CRAFT), 336
218, 220
Effectiveness of treatment Federal Employee Retirement Income Security Act, 247
Federal Employees Health Benefit Program (FEHBP), 23, 124
Federal regulation, treatment facilities, 12 Fee-for-service basis, 241Emergency room, as gateway to substance abuse
Employee assistance programs (EAPs) treatment, 187 Financial factors
client as source of payment, 19 private for-profit facilities, 13, 14 private nonprofit facilities, 13, 14 private sources, 14, 16–18 public funding, 14, 16–18 relationship to organizational factors, 16–23
Fixed budgets, payment system, 241 Full dollar value of health-related outcomes
Funding
development of, 30 and rural residents, 188
Employer-sponsored health plans, 62, 64–65behavioral health carve–out, 63–65, 238 participation rates, 64–65
Environmental factors, alcohol treatment outcome
Epidemiology, changes over time, 15–16 Epidemiology of Child and Adolescent Mental
Equity of access, and patient placement criteria,
Ethical issues, financing of substance abuse treat-
Ethnic minorities
for adolescents, 322 method, 216
public funding, 14 public funding of treatment programs, 234–236
Disorders Study (MECA), 308, 310
170–171Gamma-glutamyl transpeptidase (GGT), 401
ment, 243 Gatekeepingand access to alcoholism treatment, 117–121,
influences on, 117, 118, 121 research studies on, 117–118
criminal justice system, 14–15, 22–23,188 in rural areas, 186–188
and alcohol treatment outcome for adolescents,
and ethnic minorities, 115 and help-seeking, 114–115and patient placement criteria, 244 and substance abuse problems, 244
and alcohol treatment outcome for adolescents,
and equity to access, 170–171and help-seeking, 115
191320
Gateways to treatment
Family-involved treatment study. See also Familytherapy Gender differences
and alcoholic in treatment, 339–351 and alcoholic unwilling to seek help, 333–338 effect size calculation results, 331–332effect size measurement, 331 meta-analysis of studies, 330–332
Family pressure, and help-seeking, 115–116Family Systems Therapy (FST), 346–347
Family therapy, 329–353
320
Geographic information system (GIS), measure of
Geographical access measures, types of, 185–186 Government grants, for substance abuse research,
effectiveness of, 346–347, 350
and adolescent alcohol use, 315–316 Al-Anon, 333–334 203
geographic access, 186, 189
460 Index
Health belief model Integrated agency, services integration, 80, 81 Integrated services. See Services integrationIntegrated team, services integration, 80Intermediaries, meaning of, 232–233 Intermediate outcomes, meaning of, 379International Classification of Diseases, 376International Health Economics Association
Interorganizational relationships (IORs), 83–89
evaluation of treatment models, 181 and help-seeking, 114
consumers, 232, 243–248payer–provider–consumer relationship, 232–233payers in, 232, 233–239 providers in, 232, 239–243
Health care services
(IHEA), 204Health Economics, 203 Health economics bases of contact, 85
compatibility of goals, 85complementary treatment approaches, 85–86domain consensus, 87exchange of resources, 86interorganizational support, 87managed care arrangements, 88–89 organizational structure, 87–88similarity of organizational members, 86–87
alcoholism treatment carve-outs study, 271–283 current research areas, 204economic evaluation instruments, 253–266economic evaluation methods, 210–226elements of, 201–202future view of, 205–206journals of, 203problem drinking/health services utilization/
cost of medica1 care study, 285–295professional associations, 204and substance abuse research, 202–204substance abuse treatment financing, 229–248
Johnson Institute Intervention, 336–337
Joint Commission on Accreditation of Healthcare Organizations (JCAHO), accreditation of treatment facilities, 12–13, 36, 100, 121
effectiveness of, 337
Health Insurance Experiment (HIE), 288Health maintenance organizations (HMOs)
carve in, 32, 34, 120elements of, 29, 237
Journal of Health Economics, 203 Journals, in health economics, 203
Health plan coverage, treatment in rural areas,
Health plan purchasers 190–192 Kiddie SADS (K–SADS),310
and intermediaries, 232–233 meaning of, 232
Laboratory tests, alcohol abuse screening, 401Legal factors, financing of substance abuse treat-
Health status, alcohol use and adolescents, 322–
Help-seeking and outcome, 3
ment, 243323 Length of treatment
individual factors in, 114–117 and perceptions of patient, 182–185
Heroin, time frame and abuse, 16 HIV/AIDS, treatment services, 140,141,148HMO Act, 29Homophily perspective, elements of, 86 Hughes Act, 30
Information systems, of treatment programs, 60–
Inpatient treatment programs decrease in use of, 51–52and managed care, 52, 54–55, 118 VA substance abuse treatment evaluation, 373–
Institutional factors, patient placement criteria,
Institutional theory
and patient placement, 168Levels of care, scope of, 159–160Licensure, of treatment facilities, 12Low risk alcohol use, definition of, 397
Magellan Health Services, 109Managed care. See also Behavioral health managed
care organization (BHMCO)administrative agents, 27–28appropriateness of care hypothesis, 88 ASAM/Hay Benefits Report, 424–425common provider network hypothesis, 89 cost contaiment methods, 191definition of, 236development of system, 29–31, 423–424effects on treatment programs. See Managed
financial benefits of, 53institutional and dependency issues, 45–46and interorganizational linkages, 88–89
61
389
166–167 care and treatment programs
elements of, 44–45and managed care, 45–46
Index 461
Managed care (cont.) Medicaid (cont.)levels of participation, 21–22 Medicaid, 429–430 Medicare HMOs, 429 67 and ownership, 22 provider payment, 236–237 provider selection, 54 selective contracting, 54 derssuppression of services hypothesis, 88 and type of facility, 21 types of providers, 21, 29–30, 53, 237utilization management, 53–54, 236
Managed care and treatment programs access to services, 119–121, 426–427administrative burden, 59–60 behavioral health managed care organization
clinical criteria, standardization of, 56–58clinical recommendations, 432–433and credentialing of programs, 59 decreased utilization, 60–61, 118 economic recommendations, 432 employer-sponsored health plans, 62, 64–65financing factors, 236–237 Naltrexone, 369health care provider concerns, 430–431information systems, 60–61 and inpatient treatment programs, 54–55 managed care network participation, 57 Medicaid, 66–67participation rates, 54–55potential managed care revenue, 57 practice guidelines, 58 and private for–profit facilities, 22, 52problems of, 427–428 program consolidation, 61–62 program operations and staffing, 56 responsibility of managed care, 433 state employee health plans, 65–66substance abuse treatment, 420–433 utilization rates, 427 workforce characteristics, 59
alcohol abuse screening, 397–402alcohol use definitions, 397brief intervention, 402–410 policy/system issues, 410–412
managed care programs, 429–430 mental health and substance abuse benefits, 66–
substance abuse treatment financing, 246 Medicare HMOs, 429 Mental health disorders. See Co-occurring disor-
Mental Health Parity Act, 124, 247 Mental Health Program for Youth, 79 Methadone clinics
minimal services of, 140 types of services of, 141
Methodological studies, economic evaluation stud-
Michigan Alcoholism Screening Test (MAST-l0),
Minimal spouse involvement (MSI), 344 Minnesota Model, 394 Modified Therapeutic Community, 82 Motivational enhancement therapy (MET), 367 Multisystemic Therapy (MST), 315–316
ies, 213, 214, 215, 216, 217, 218, 220
(BHMCO), 422–423 286, 399
National Alcohol Survey, 101 National Committee for Quality Assurance
(NCQA), activities of, 36–37, 45, 100, 121, 273 National Comorbidity Survey (NCS), 421 National Drug and Alcohol Treatment Utilization
National Health Interview Survey (NHIS83), 288 National Household Drug Survey, 101 National Institute of Alcohol Abuse and Alcohol-
Survey (NDATUS), 51, 59
ism (NIAAA), 30 research projects of, 203
National Institute on Drug Abuse (NIDA), research
National Institute of Health (NIH), 100 National Institute of Mental Health (NIMH), re-
search projects of, 203 National Longitudinal Alcohol Epidemiology Sur-
vey, 101 Need for services
projects of, 203
Managed care treatment setting, 393–412
behavioral health managed care organization (BHMCO) definition, 109–110
patients’ perceived need, 182–183
and administrative agents, 38 behavioral health managed care organization
Managed indemnity, meaning of, 237 Marijuana, time frame and abuse, 16 Marital therapy. See Family therapy
behavioral health expenses, 119 behavioral health managed care organization
and DATFin, 263
Network development
Medicaid, 19 (BHMCO), 37–38Nurse visits, 363
Older adults, brief intervention for, 409–410Opportunity cost approach, DATCAP, 255–256
(BHMCO), 31, 237–238
462 Index
Organizational factors, 11–13 Posttraumatic stress disorder (PTSD), veteran sub-
Practice guidelines, and managed care, 58 Preferred provider organization (PPO), elements
Pregnant women, substance abuse in rural areas,
Prenatal treatment, as gateway to substance abuse
Pressure to Change (PTC), 335–336effectiveness of, 335–336, 338
federal/state regulation, 12–13 level of affiliation, 12 licensing, 12 relationship to financial factors, 16–20 setting, 12 type of care, 11 187
stance abuse, 374, 378, 380
of, 29, 237
Outcome. See Treatment outcome Outpatient programs, continuing care, 357–370 Ownership of facility
treatment, 187
and access to substance abuse treatment, 142,
and financing patterns, 18 and managed care, 22 231and organizational objectives, 13 of treatment facility, 13, 16, 17
150 Prevailing charges, 240Primary care setting, substance abuse treatment,
Private facilities, financing of, 14, 16–18 Private for-profit facilities. See also Inpatient treat-
ment programs client payments, 19 financial factors, 13, 14, 18 inpatient, decrease in use over time, 51–52 and managed care, 22, 52
Private insurance, substance abuse treatment fi-
Private nonprofit facilities financial factors, 13, 14, 18–19and managed care, 22
Parity coverage, mandates for, 101–102 Patient placement criteria, 157–171
and access to higher level of care, 166–168 adolescents, 168 and age, 166 cognitive impairment, 162 nancing, 245–246 dimensions of symptom severity, 159,161 dual diagnosis, 162–163and equity of access, 170–171to improve access to treatment, 168–171institutional factors, 166–167 length of stay, 168 and levels of care, 159–160and patient knowledge about treatment, 163–
and patient preferences, 163 and practice guidelines, 158–160and social network, 164–166
of substance abuse treatment, 232 types of, 232
Payment system sample statistics, 291–292 capitation, 241–242 survey instruments, 286 fixed budgets, 241 survey response rates, 291 payment to providers, 240–241per case, 241 traditional system, 241 and two- or three-tiered system, 240
Problem drinking, definition of, 108,397 Problem drinking/health services utilization/cost
of medical care study, 285–295analysis of findings, 295–296conceptual framework, 287–288
estimation approach, 288–290 estimation challenges, 288–289 estimation results, 292–295
recruited subjects, 290 sample design, 290
164 data collection, 290
Payers instrumentation, 291
Professional associations, health economics, 204 Program on Chronic Mental Illness, 79 Project COMBINE, 405 Project GOAL, 409–410Project MATCH, 364, 382, 385–386, 387, 404, 405 Project TrEAT, 404, 406, 409 Provider selection, managed care, 54 Provider-to-population ratios, measure of geo-
Providers
Perception of treatment, aspects of, 181–185 Performance indicators, substance abuse treat-
Pharmacotherapy, and adolescent alcohol use, 317 Physicians, training in alcohol treatment, 411–412 graphic access, 185–186Point of service (POS), elements of, 237 Political factors payment system, 240–241
ment, 369
access to alcoholism treatment, 123–124 related to managed care, 120–121
of substance abuse treatment, 239–243 types of, 232
Index 463
Proximal outcomes, meaning of, 379 Public facilities access to, 147–148
Self-help programs
demand for addiction services, 122–123 financing of, 14, 16–18 no-pay clients, 19 substance abuse treatment, 247–248
and adolescents, 314–315, 321 Alcoholics Anonymous (AA), 111
uses of, 231 and VA substance abuse treatment outcome,
Service systems, and rural areas and access to
Services integration
types of clients of, 142 381–382, 384, 386, 387
Quality of care treatment, 190–191 behavioral health managed care organization
rural areas, 189 (BHMCO), 36–37 brokered model, 80, 81
coordination and integration difficulties, 79 effectiveness of, 81–82 integrated agency, 80, 81 integrated team, 80 interorganizational relationships (IORs), 83–89
and size of organization, 89 types of programs, 78–79
Recovery, long-term, factors related to, 367–368 Regulation, of treatment facilities, 12 Rehabilitation Accreditation Commission (CARF),
Relapse100,121 service linkages, 82–83
adolescent treatment outcome, 320–321 continuing care as prevention, 357–370 factors related to, 366 150
Setting of services, and access to care, 142, 148–
Sobriety contract, 350, 352 Relapse prevention, access to, 147–148 Risk-sharing Social support
and behavioral health care, 53,191 elements of, 36, 42–43substance abuse treatment financing, 239
and patient placement criteria, 164–166 pressure to seek help, 115–116 social support and women, 165
Robert Wood Johnson Foundation, Substance
Rural Alcohol Study, 179,181–182, 184, 188 Rural areas and access to treatment, 177–192
Societal factors, access to alcoholism treatment,
Socioeconomic status, and help-seeking, 116–117 Specialty substance abuse treatment system, 11–
Abuse Policy Research Program (SAPRP), 203 122–124
and border crossing, 186 22 conceptual model of access/process/outcomes,
gateways to treatment, 186–188 geographical access measures, problems of,
client characteristics, 14–16
managed care, role of, 21–22 organizational characteristics of, 11–13
179–181 financial characteristics of, 13–14
185–186 organizational-financial interrelationships, 16– 20
Staff models, behavioral health managed care or-ganization (BHMCO), 422
Standardization, clinical criteria, 56–58State employee health plans, 65–66
behavioral health carve-out, 65–66, 238community service models, 82
and health plan coverage, 190–192 and patient perception of need, 182–183and perceived access, 183–185and perceived treatment effectiveness, 183 quality of care, 189 rurality, dimensions of, 178–179and service systems, 190–191and sustained involvement in treatment, 188– State regulation, treatment facilities, 12
Stress, and adolescent alcohol use, 322 Structured Clinical Interview for DSM, 310 Substance abuse
189
Satisfaction surveys, NCQA requirements, 37 Selective contracting
elements of, 236 and managed care, 54 and rural residents, 191
as chronic condition, 247, 248, 369, 380–381demographic factors, 244 medicalization of, 430 predominant drugs used (1970s–1990s), 15–16 societal cost of, 419, 421
Substance Abuse Policy Research Program Selectivity bias, in program evaluation, 215 Self-change efforts, and adolescent alcohol use,
317 (SAPRP), 203
464 Index
Substance abuse research, and health economics,
Substance abuse treatment
VA substance abuse treatment evaluation, 373–
Treatment Outcome Prospective Study (TOPS),
Treatment programs, deficiencies of, 76 Treatment services. See also specific types of pro-
access to. See Access to alcoholism treatment cyclical trends, 22 decline in use, 60–61, 118, 138–140 and managed care. See Managed care and treat-
nonspecialty services, 10 private for-profit facilities, 13, 14, 18 private nonprofit facilities, 13, 14, 18–19 public facilities, 14, 16–18
202–204 389
access to. See Access to substance abuse treat-
performance indicators, 369 in primary care setting, 231 public facilities, 247–248 self-help groups, 231 types of services, 140, 142–143 VA substance abuse treatment evaluation, 373–
139, 313 ment
grams
389 ment programsSubstance abuse treatment financing, 229–248
adequacy of benefits, 247 adverse selection issue, 239 behavioral health managed care organization
capitation, 241–242 specialty services, 9–10, 11–22 carve-outs, 242–243and chronic client, 248 and consumers, 243–248 decision-making of payers, 238–239and demand for treatment, 243–244 ethical and legal issues, 243 and expansion of insurance coverage, 247 historical view, 233–234 managed care, 236–237, 420–433 Medicaid, 246 and multiple needs of clients, 246–248 ongoing funding changes, 239 and payers, 232 payments to providers, 240–241 per case payment systems, 241 private insurance, 245–246 and providers, 239–243 public sector funding, 234–236 risk-sharing, 239 methods of, 236
(BHMCO), 237–238 settings for, 9–10
use of term, 3 variation in treatment practices, 4, 28
Treatment success, definition of, 221 Tuberculosis screening, treatment service, 140,
Twelve step programs, basic model, 85–86
Uniform Facility Data Set (UFDS), 51, 140 Unilateral Family Therapy (UFT), 334–335
Uninsured Americans
141, 148
effectiveness of, 334–335, 338
and access to services, 121 and substance abusers, 244
United Behavioral Health, 56 alcoholism treatment carve–outs study, 273–283
Utilization management, 53–54 behavioral health managed care organization
(BHMCO), 422
traditional payment systems, 241 tools of, 53 Support services, access to, 148
Temporary Assistance to Needy Families (TANF),
TennCare Partners, 67, 430 389Traditional payment systems, substance abuse
treatment financing, 241 Transaction cost economics, behavioral health
managed care organization (BHMCO), 41–44 Treatment engagement, meaning of, 158 Treatment improvement protocols (TIPS), 189–190 Treatment outcome
alcohol treatment for adolescents, 307–323 continuing care, 357–370 family therapy, 329–353 managed care setting, treatment in, 393–412
Utilization review, and behavioral health managed care organization (BHMCO), 30
123 VA substance abuse treatment evaluation, 373–
conceptual framework of study, 374–375 continuing care, 380–382, 386–387 discharge information, 375 follow-up assessments, 376 inpatient phase, 377–380 length of inpatient stay, 377 participants in study, 375 patient characteristics, 376 patient improvement, 376–377, 385 patient-treatment matching, 382–384, 387 process analysis, 379–380
Index 465
VA substance abuse treatment evaluation (cont .) and PTSD patients, 374, 378, 380 and self-help groups, 381–382, 384, 386, 387 treatment environment, 378 treatment orientation and outcome, 378–380,
Veterans, treatment of. See VA substance abuse
Washington Circle, 100 Women
and co-occurring disorders, 114–115, 162–163 engagement rates, 165 and help-seeking, 116
385–386 and social support, 165
treatment evaluation ment, 187–188 Worksite, as gateway to substance abuse treat-